Shanmuga Hospital Ltd has initiated a pilot public testing phase of its mobile application, Shanmuga 360, to validate operational performance and gather user feedback. The digital healthcare application is intended to provide patients with convenient access to various healthcare services through a single platform. This move aims to ensure operational stability, user experience, security, and service efficiency before a full-scale rollout.

The application has been made available on the Google Play Store and Apple App Store for the limited purpose of operational testing. During this pilot phase, certain features and services have been enabled in a controlled manner, and access may be restricted to specified testing periods. The company stated that the present availability of the application does not constitute its official commercial launch.

Testing and Validation

The pilot rollout is focused on performance validation and the collection of user feedback. The company has emphasized that the application is still undergoing testing to ensure all intended features and services are fully operational. The official commercial launch will be undertaken only upon the successful completion of this testing process.

Future Announcements

Shanmuga Hospital Ltd will make a separate announcement to the Stock Exchange regarding the official commercial launch at the appropriate time. This disclosure was made in the interest of transparency, as the application has been made available in the public domain for pilot testing purposes.

Shanmuga Hospital Limited has been empanelled with the Central Government Health Scheme (CGHS), Ministry of Health & Family Welfare, Government of India, for a period of three years effective June 19, 2026. The empanelment allows the hospital to provide healthcare services to Central Government employees, pensioners, and other eligible beneficiaries notified by the government. This development is expected to broaden the hospital's patient base and enhance accessibility to its medical facilities under a government healthcare scheme.

The company received an Office Memorandum dated July 6, 2026, confirming the empanelment in accordance with the terms and conditions of the Memorandum of Agreement. The agreement falls within the ordinary course of business of the company. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Details of the Agreement

The following table outlines the key particulars of the Memorandum of Agreement:

The hospital is mandated to provide medical treatment and services to eligible beneficiaries subject to the terms of the MoA and applicable CGHS guidelines. The transaction does not fall within related party transactions, and the promoter group has no interest in the entity.